LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC)
Publication
, Journal Article
GARG, S; GARG, PK; ZALUTSKY, MR
Published in: JOURNAL OF NUCLEAR MEDICINE
May 1, 1993
Duke Scholars
Published In
JOURNAL OF NUCLEAR MEDICINE
ISSN
0161-5505
Publication Date
May 1, 1993
Volume
34
Issue
5
Start / End Page
P99 / P100
Publisher
SOC NUCLEAR MEDICINE INC
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
GARG, S., GARG, P. K., & ZALUTSKY, M. R. (1993). LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC). JOURNAL OF NUCLEAR MEDICINE, 34(5), P99–P100.
GARG, S., P. K. GARG, and M. R. ZALUTSKY. “LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC).” JOURNAL OF NUCLEAR MEDICINE 34, no. 5 (May 1, 1993): P99–100.
GARG S, GARG PK, ZALUTSKY MR. LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC). JOURNAL OF NUCLEAR MEDICINE. 1993 May 1;34(5):P99–100.
GARG, S., et al. “LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC).” JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, SOC NUCLEAR MEDICINE INC, May 1993, pp. P99–100.
GARG S, GARG PK, ZALUTSKY MR. LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC). JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 1993 May 1;34(5):P99–P100.
Published In
JOURNAL OF NUCLEAR MEDICINE
ISSN
0161-5505
Publication Date
May 1, 1993
Volume
34
Issue
5
Start / End Page
P99 / P100
Publisher
SOC NUCLEAR MEDICINE INC
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences